HIMS: Hims & Hers Health, Inc.
About
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Current Value
$31.291 Year Return
Current Value
$31.291 Year Return
Key Details
Market Cap
$6.74B
P/E Ratio
71.36
1Y Stock Return
247.02%
1Y Revenue Growth
56.70%
Dividend Yield
0.00%
Price to Book
15.3
Strategies that include HIMS
Stock's related to HIMS
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| BEAM | 47.73% | $2.34B | -4.28% | 0.00% |
| NTLA | 43.67% | $1.60B | -49.08% | 0.00% |
| NCLH | 40.71% | $12.47B | +62.00% | 0.00% |
| ABCL | 38.96% | $894.96M | -34.70% | 0.00% |
| AHCO | 38.82% | $1.35B | +9.13% | 0.00% |
| DMRC | 38.72% | $739.44M | +2.07% | 0.00% |
| DDD | 38.04% | $378.38M | -51.22% | 0.00% |
| CRSP | 37.96% | $4.71B | -22.88% | 0.00% |
| DNLI | 37.86% | $3.69B | +36.55% | 0.00% |
| PUBM | 37.63% | $803.91M | -2.09% | 0.00% |
| NVCR | 36.68% | $3.23B | +129.79% | 0.00% |
| LGND | 36.17% | $2.32B | +104.94% | 0.00% |
| BIGC | 36.14% | $569.82M | -22.33% | 0.00% |
| RXRX | 35.62% | $2.95B | +2.29% | 0.00% |
| CARS | 35.40% | $1.29B | +5.00% | 0.00% |
| PDSB | 35.31% | $80.43M | -59.28% | 0.00% |
| ARCT | 35.19% | $504.91M | -22.30% | 0.00% |
| DORM | 35.01% | $4.29B | +82.37% | 0.00% |
| TDOC | 34.85% | $1.98B | -39.57% | 0.00% |
| STRL | 34.76% | $5.97B | +198.71% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TRV | -0.01% | $59.82B | +43.85% | 1.55% |
| IDA | -0.04% | $6.23B | +18.61% | 2.85% |
| TPST | 0.17% | $41.52M | -71.85% | 0.00% |
| ELV | -0.23% | $95.18B | -15.05% | 1.55% |
| LUMN | 0.26% | $7.09B | +348.08% | 0.00% |
| INFY | 0.27% | $92.18B | +25.49% | 2.61% |
| KEP | 0.29% | $10.99B | +17.42% | 0.00% |
| BCE | 0.31% | $24.67B | -33.40% | 10.72% |
| SYK | 0.35% | $148.53B | +33.92% | 0.82% |
| GO | 0.37% | $1.94B | -31.48% | 0.00% |
| HES | -0.40% | $45.28B | +3.72% | 1.23% |
| DGX | -0.44% | $18.03B | +17.47% | 1.83% |
| MCK | -0.44% | $78.87B | +35.27% | 0.43% |
| UTZ | 0.46% | $1.42B | +24.40% | 1.36% |
| CWAN | 0.55% | $7.10B | +62.21% | 0.00% |
| MKC | 0.57% | $21.03B | +17.34% | 2.14% |
| RCI | 0.60% | $19.16B | -20.01% | 4.09% |
| SLGN | -0.61% | $6.11B | +31.96% | 1.33% |
| CI | 0.62% | $93.75B | +28.20% | 1.61% |
| SRPT | -0.63% | $12.22B | +48.57% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ACGL | -16.15% | $37.36B | +27.37% | 0.00% |
| NERV | -15.48% | $15.81M | -65.28% | 0.00% |
| ABBV | -14.86% | $321.21B | +26.10% | 3.41% |
| CBOE | -14.35% | $22.18B | +16.57% | 1.10% |
| CB | -13.44% | $116.86B | +27.09% | 1.21% |
| PULM | -12.61% | $23.16M | +215.42% | 0.00% |
| CASI | -12.48% | $52.91M | -33.31% | 0.00% |
| WM | -12.42% | $90.36B | +29.09% | 1.00% |
| OMCL | -12.34% | $2.20B | +35.70% | 0.00% |
| CL | -11.94% | $79.34B | +22.96% | 2.05% |
| PG | -11.68% | $423.20B | +18.18% | 2.21% |
| ASPS | -11.48% | $22.14M | -81.89% | 0.00% |
| RSG | -11.44% | $67.32B | +32.23% | 1.02% |
| CMLS | -11.31% | $13.23M | -84.30% | 0.00% |
| CYCN | -10.72% | $6.34M | +3.08% | 0.00% |
| PGR | -10.49% | $154.68B | +61.58% | 0.43% |
| TKC | -9.93% | $5.75B | +32.33% | 1.31% |
| HLN | -9.80% | $43.77B | +14.17% | 1.62% |
| KMB | -9.78% | $46.54B | +12.39% | 3.48% |
| LNG | -9.77% | $49.94B | +27.79% | 0.80% |
ETF's related to HIMS
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XONE | 0.12% | $550.19M | 0.03% |
| FTXG | 0.42% | $31.94M | 0.6% |
| IAK | 0.89% | $800.30M | 0.39% |
| FTSD | 0.89% | $183.45M | 0.25% |
| THTA | 1.02% | $32.40M | 0.49% |
| CSHI | -1.12% | $493.76M | 0.38% |
| VRIG | 1.15% | $1.10B | 0.3% |
| TBLL | 1.41% | $1.94B | 0.08% |
| IBHD | -1.42% | $320.14M | 0.35% |
| FBY | 1.47% | $142.09M | 0.99% |
| FTSM | 1.54% | $6.04B | 0.45% |
| EIDO | 1.57% | $299.94M | 0.59% |
| AGZD | -1.69% | $132.76M | 0.23% |
| XLP | 1.72% | $16.79B | 0.09% |
| JBBB | 1.81% | $1.35B | 0.49% |
| HYEM | 1.92% | $410.22M | 0.4% |
| PULS | 2.04% | $8.93B | 0.15% |
| GSY | 2.17% | $2.35B | 0.23% |
| SPTS | 2.20% | $5.58B | 0.03% |
| IBTG | 2.32% | $1.50B | 0.07% |
News
SeekingAlpha
Hims & Hers achieved a 44% YoY increase in Q3 2024, surpassing 2 million active users. Find out what positions HIMS as a key player in digital health landscape.
SeekingAlpha
Dow outshined Nasdaq and benchmark S&P 500. Gold sinks by most in 4 years.
Yahoo
Hims & Hers Health (HIMS) has soared after Hunterbrook Media says that the company could benefit from President-elect Donald Trump's Food and Drug Administration (FDA) nomination Marty Makary. Julie Hyman and Josh Lipton break down what investors need to know on Market Domination. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Naomi Buchanan.
Yahoo
As the U.S. markets continue their upward momentum with the S&P 500 extending its winning streak, investors are increasingly focusing on growth companies that demonstrate strong potential for significant earnings increases. In this environment, stocks with high insider ownership often stand out as they can indicate confidence from those closest to the company's operations.
Finnhub
SAN FRANCISCO-Hims & Hers Health, Inc. , the leading health and wellness platform, today announced that Hims & Hers customers will now be able to supplement their treatment plan with daily meal...
Yahoo
SAN FRANCISCO, November 21, 2024--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced that Hims & Hers customers will now be able to supplement their treatment plan with daily meal replacement bars and shakes to support them on their comprehensive weight loss journey.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.